Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II of Cilengitide in Recurrent Malignant Glioma
NCT00006093Phase 2Completed
- Sponsor
- New Approaches to Brain Tumor Therapy Consortium
- Start
- Sep 2000
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cilengitide in malignant glioma, sponsored by New Approaches to Brain Tumor Therapy Consortium. Started Sep 2000; status: completed.
02
Drugs
cilengitide
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00006093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006093.